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Abstract
Background: Conduction disorders (CD) and atrial arrhythmias (AA) in the postoperative 
period of cardiac surgery impede prompt clinical recovery and prolong hospitalization. Mitral 
valve repair (MVR) has become the treatment of choice for patients with significant valvular 
regurgitation, but information on CD and AA in this population is scarce.
Methods: Records of consecutive patients undergoing MVR at a single center were reviewed. 
Patients with a preoperative pacemaker, CD, prior cardiac surgery or concomitant MVR were 
excluded. A total of 290 patients were included in the final analysis. Electrocardiograms pre- 
and post-operatively were analyzed for CD and AA.
Results: CD occurred in 69 (23.7%) patients: 47 (16.2%) had first degree atrio-ventricular 
block (AVB), 10 (3.4%) had Mobitz I, 3 (1.03%) had Mobitz II, and 9 (3.1%) complete AVB. 
Only 6 (2.0%) patients required pacemakers. Univariate predictors of AVB were age, pree-
xisting right bundle branch block (RBBB), mitral valve ring size, and bypass time. The only 
multivariate predictors of AVB were bypass time and preexisting RBBB (OR 3.23 and 1.98, re-
spectively). The most common AA was atrial fibrillation 13.1% (38 patients) followed by atrial 
flutter 2.7% (8 patients). Multivariate predictors of AA were age and left atrial size (OR 1.85 
and 4.2, respectively). Length of stay in patients with CD or AA was prolonged 2.2 ± 2 days  
compared to controls (p < 0.05).
Conclusions: In this large sample of patients undergoing MVR, we found that bypass time 
and preexisting RBBB were independent predictors of CD; age and left atrial size were inde-
pendent predictors of AA. (Cardiol J 2014; 21, 5: 569–575)
Key words: conduction disorder, atrio-ventricular block, atrial fibrillation, atrial 
flutter, mitral valve repair, pacemaker
Introduction
The development of conduction disorders 
(CDs) has been well described after coronary ar-
tery bypass grafting (CABG) and valvular surgery, 
occurring in 10–20% of patients with 1–3% ultima-
tely requiring permanent pacemaker implantation 
(PPI) [1–6]. In addition, atrial arrhythmias (AAs) 
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occur in up to 60% of patients undergoing cardiac 
surgery [7–9]. Both postoperative CDs and AAs can 
have significant clinical consequences, impeding 
prompt recovery and prolonging hospitalization.
Mitral regurgitation remains a common prob-
lem with 40,000 patients undergoing mitral valve 
surgery each year in the United States [10]. Surgi-
cal mitral valve repair (MVR) is the gold standard 
procedure for patients who require surgery for 
degenerative mitral valve regurgitation and MVR 
[11].There are only 2 small studies examining 
CDs in patients undergoing MVR. The first study 
included 115 patients and showed an incidence 
of CDs of 23% and PPI in 2.6% [12]. The second 
study included 391 patients undergoing mitral 
valve surgery (147 with MVR) and showed CDs 
in 23.5% and PPI in 4% [13]. Understanding the 
risk factors and natural history of CD and AA in 
patients undergoing MVR may influence both the 
timing of pacemaker implantation and the strategy 
to restore sinus rhythm. In light of the scarcity of 
contemporary data in this area, we sought to in-
vestigate the incidence, predictors, and evolution 
of CDs and AAs after MVR.
Methods
Data were retrospectively reviewed from all 
patients with degenerative mitral valve prolapse 
operated on for mitral regurgitation as the primary 
indication by a single surgeon (D.H.A.) and his 
team between March 2008 and December 2010. 
During this period, 308 consecutive patients unde-
rwent MVR. Patients undergoing concomitant car-
diac surgery such as tricuspid valve repair (TVR), 
CABG, patent foramen ovale (PFO) closure, and 
MAZE, were included in the study population. We 
excluded from this study patients with permanent 
or transient cardiac pacing or complete atrioven-
tricular (AV) block before surgery (n = 4), patients 
undergoing repeat cardiopulmonary bypass (n = 2), 
patients undergoing septal myomectomy (n = 2), 
those with mitral stenosis (n = 3), and aortic ste-
nosis (n = 7).
The study was approved by the local bioethical 
committee and all patients gave their informed 
consent.
Surgical technique
Valve repairs were performed by means of 
standard reconstructive techniques; sequentially 
repairing the posterior leaflet, to perform a true-
-sized annuloplasty with a complete semirigid re-
modeling ring, and then to repair any residual pro-
lapse of the anterior leaflet or commissures after 
inspection of the line of closure during testing with 
saline solution. We typically performed posterior 
leaflet repair by targeted resection (quadrangular 
or triangular) of any prolapsing segment, reducing 
the posterior annular dimension if appropriate 
and then reconstructing the posterior leaflet. In 
the setting of excess posterior leaflet tissue, we 
typically performed a sliding leaflet plasty to redu-
ce the height of the posterior leaflet to 1–1.5 cm 
in all segments. In valves with minimal tissue, 
the prolapse was corrected by limited triangular 
resections or insertion of artificial polytetrafluo-
roethylene chordae or loops or by native chordal 
transfer. Artificial chordae were also often used to 
reinforce the posterior leaflet resection repair or 
to displace further the closure line.
All patients (except 7 that underwent minimal-
ly invasive surgery) underwent median sternoto-
my, and cardiopulmonary bypass was established 
via cannulation of the ascending aorta and right 
atrium. Cardioplegia and systemic hypothermia 
was performed according to standard surgical 
techniques. Temporary epicardial pacemaker leads 
were implanted during surgery for every patient. 
Cardiopulmonary bypass time and the size of the 
annuloplasty ring were recorded for each patient.
Medical record review
Standardized data forms were used to extract 
pertinent data from the medical record regarding 
details of demographics and medical history. 
Preoperative records were evaluated for each 
patient in order to examine baseline characteri-
stics, comorbidities, and use of antiarrhythmic or 
AV nodal blocking medications prior to surgery. 
Preoperative echocardiograms were also reviewed 
to assess baseline ventricular function and severity 
of valvular disease. In order to assess for the 
development of conduction disturbances, 12 lead 
electrocardiograms (ECGs) were reviewed inde-
pendently by 2 cardiologists. Preoperative ECGs 
were examined for baseline CDs and AAs. All 
postoperative ECG were reviewed with particular 
attention paid to the ECG 24 h after surgery and 
the ECG at time of discharge. When available, 
a follow-up ECG 4 or more weeks after the surgery 
was also reviewed. While AV block was the pri-
mary conduction abnormality of interest, bundle 
branch block, hemi-blocks, and junctional rhythms 
were all documented. Postoperative ECGs were 
also reviewed for new AA (atrial tachycardia, atrial 
fibrillation [AF], or atrial flutter). All PPIs, cardio-
versions for AAs, and length of hospitalization for 
each patient were recorded.
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Statistical analysis
The following variables were included in 
the analysis: age, race, gender, height, weight; 
history of coronary artery disease, hypertension, 
heart failure, diabetes, pulmonary disease; preo-
perative medications including calcium-blockers, 
beta-blockers, amiodarone, digoxin, sotalol, other 
anti-arrhythmics; electrocardiographic parameters 
including PR interval, QRS duration, right bundle 
branch block (RBBB), left bundle branch block 
(LBBB), left and posterior hemi-blocks; echocar-
diographic parameters including left ventricular 
ejection fraction (LVEF), left ventricle (LV) right 
ventricle (RV); left atrium (LA), right atrium (RA) 
size and function; procedural characteristics inclu-
ding bypass time, mitral ring size, Maze, TVR, tri-
cuspid ring size. Continuous data were expressed 
as mean ± standard deviations, and categorical data 
were expressed as numbers and percentages. Con-
tinuous data were analyzed using Mann-Whitney 
test, and categorical data were compared using c2 
and Fisher’s exact tests, when needed. Potential 
predictors of CD and AA were first identified 
using univariate logistic regression analyses, with 
a threshold of p < 0.05, then included as indepen-
dent variables in multivariate regression models. 
Correlation analyses were performed between 
continuous variables. Multivariate odds ratios 
(ORs) and corresponding confidence intervals 
(CIs) were presented for each variable included 
in the regression model. All statistical analyses 
were performed using the Statistical Package for 
the Social Sciences (SPSS Inc.).
Results
A total of 290 patients were included in the 
final analysis after the exclusion criteria mentioned 
above. Baseline clinical characteristics are listed in 
Table 1. Most patients had prolapse of the posterior 
leaflet of the mitral valve (75%), with a mean age 
56 ± 13 years, 35% of the patients were females, 
the mean LVEF was 55 ± 9%, length of stay was 
5 ± 6 days, bypass time was 145 ± 65 min, mean 
annuloplasty ring size was 32 mm, successful MVR 
was achieved in all patients and the in-hospital 
mortality was zero.
Incidence of conduction disorders  
and atrial arrhythmias
CD occurred in 69 (23.7%) patients: 47 (16.2%) 
had first degree AV block, 10 (3.4%) had Mobitz 
I, 3 (1.03%) had Mobitz II, and 9 (3.1%) complete 
AV block. Fifty percent of patients with Mobitz I, 
66% with Mobitz II and 44% with complete AV 
block resolved to first degree AV block. The most 
common AA was AF 13.1% (38 patients) followed 
by atrial flutter 2.7% (8 patients).  
Univariate and multivariate  
predictors of AV block
The results of the univariate analysis are 
presented in Table 2. Univariate predictors of AV 
block were age, preexisting RBBB, mitral valve 
ring size, and bypass time. The only multivariate 
predictors of AV block were bypass time and pree-
xisting RBBB (OR 3.23, 95% CI 1.45–7.21 and 1.98, 
95% CI 1.11–4.87, p < 0.05, respectively). All the 
other variables including age, race, gender, history 
of coronary artery disease, hypertension, heart 
failure, diabetes, pulmonary disease; preoperative 
medications, ECG parameters, echocardiographic 
parameters including LVEF, LV, RV, RA size and 
function and procedural characteristics including 
mitral ring size, Maze, TVR, and tricuspid ring size, 
lacked statistical significance.
Univariate and multivariate  
predictors of atrial arrhythmias
The results of the univariate analysis are 
presented in Table 3. Univariate predictors of AA 
were LA enlargement (RR 4.89, 95% CI 2.30– 
–12.27; p < 0.05), RA enlargement (RR 1.79, 95% CI 
1.11–4.87; p < 0.05), age (RR 3.46, 95% CI 1.30–
–7.19; p < 0.05), hypertension (RR 1.58, 95% 
CI 1.07–7.97; p < 0.05), and LV or RV dysfunction 
(RR 1.87, 95% CI 1.28–3.15 and 1.72, 95% CI 
1.13–5.58; p < 0.05, respectively).
Table 1. Baseline clinical characteristics.
Demographics
Age 56 ± 13 
Female 35.3%
Leaflet involvement
Isolated posterior 75%
Isolated anterior 6%
Bileaflet 19%
Cardiac co-morbidity
LVEF [%] 55 ± 9
Moderate to severe MR 6.5%
Severe MR 93.5%
Previous MI 2.3%
Coronary artery disease 10.8%
LVEF — Left ventricular ejection fraction; MR — mitral regurgita-
tion; MI — myocardial infarction
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Multivariate predictors of AA were age and 
LA enlargement (OR 1.85, 95% CI 1.38–3.15 and 
4.2, 95% CI 2.98–8.11; p < 0.05, respectively). All 
the other variables including race, gender, history 
of coronary artery disease, hypertension, heart 
failure, diabetes, pulmonary disease; preoperative 
medications, ECG parameters, echocardiographic 
parameters including LVEF, LV, RV, RA size and 
function and procedural characteristics including 
bypass time, mitral ring size, MAZE, TVR, and 
tricuspid ring size, lacked statistical significance.
Clinical implications
Length of stay in patients with CD or AA was 
significantly prolonged by 2.2 ± 2 days compared 
to controls (p < 0.05). Out of 46 patients with AA, 
16 (35%) patients with AA required electrical 
cardioversion. Out of 10 patients with Mobitz I, 
5 recovered AV conduction with residual first 
degree AV block. In 3 patients with Mobitz II, 
2 recovered normal AV conduction and 1 with 
residual first degree AV block. In 9 patients with 
complete AV block, 5 recovered AV conduction 
with residual first degree AV block. The mean 
time to recovery was 3 ± 2 days. Only 6 (2%) 
patients required pacemakers (4 due to AV block 
and 2 due to sinus bradycardia). The fatality rate 
was zero, therefore we could not assess the poten-
tial impact of CD and AA on mortality in patients 
undergoing MVR.
Table 2. Univariate predictors of conduction disorders.
Variables RR 95% CI P
Demographics
Age* 2.43 1.22–4.88 0.045
Race 0.32 0.04–3.30 0.345
Gender 0.48 0.14–1.65 0.247
Coronary artery disease 0.95 0.93–1.01 0.901
Hypertension 2.65 0.90–7.15 0.085
Congestive heart failure 1.02 0.22–4.60 0.967
Diabetes 1.09 0.31–3.99 0.988
Pulmonary disease 0.57 0.22–1.15 0.246
Perioperative CCB 0.59 0.28–1.55 0.347
Perioperative beta-blockers 0.46 0.17–1.09 0.090
Perioperative antiarrhythmic 0.85 0.33–2.11 0.788
Perioperative digoxin 0.32 0.03–3.21 0.344
Electrocardiographic parameters
PR interval 2.64 0.96–6.99 0.059
QRS duration 1.78 0.44–8.01 0.540
Right BBB* 2.88 1.05–8.10 0.040
Left BBB 1.23 0.41–5.62 0.821
Hemiblocks 1.18 0.29–3.98 0.962
Echocardiographic parameters
Left ventricular ejection fraction 0.67 0.38–1.25 0.845
Left ventricle size 1.81 0.91–3.61 0.122
Right ventricle dysfunction 0.96 0.93–1.06 0.090
Right atrium size 1.61 0.24–3.26 0.112
Left atrium size 1.64 0.33–7.99 0.499
Operative variables
CPB time* 6.19 2.31–16.01 0.009
Mitral ring size* 4.01 1.40–31.00 0.041
MAZE 5.03 0.44–49.22 0.187
Tricuspid valve repair 3.99 0.95–21 0.500
Tricuspid ring size 0.86 0.27–2.68 0.771
*Asterisks identify statistically significant predictors of conduction disorders. Perioperative antiarrhythmics include sotalol and amiodarone; 
BBB — bundle branch block; CCB — calcium channel blocker; CI — confidence interval; CPB — cardiopulmonary bypass time; RR — relative risk
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Discussion
Understanding the risk factors and natural 
history of CD and AA in patients undergoing MVR 
may influence the perioperative management of 
temporary pacemakers, decision of pacemaker 
implantation and prophylactic or therapeutic stra-
tegies to maintain or restore normal sinus rhythm. 
In view of the paucity of contemporary data in this 
area, we sought to investigate the incidence, pre-
dictors, and evolution of CDs and AAs after MVR. 
The main findings of our study in patients under-
going surgical MVR are: 1) a significant proportion 
of patients undergoing MVR with CD had improved 
AV conduction (55%) within 3 ± 2 days; 2) only 
2.4% patients required pacemakers; 3) bypass time 
and preexisting RBBB were predictors for the de-
velopment of CD after MVR; 4) the incidence of AA 
was low, the most common AA was AF followed by 
atrial flutter, and 35% patients required electrical 
cardioversion; 5) predictors of AA were age and LA 
size; 6) hospitalization in patients with CD or AA 
was prolonged 2.2 ± 2 days compared to controls.
Compared to previous studies the incidence of 
CD in our cohort was marginally lower. Meimoun 
et al. [12] reported on the incidence of AV block 
in patients undergoing MVR over a decade ago. 
The investigators observed an incidence of 6% of 
complete AV block, 3% of second degree AV block 
and 14% first degree AV block. A lower number of 
Table 3. Univariate predictors of atrial arrhythmias.
Variables RR 95% CI P
Demographics
Age* 1.44 1.12–6.70 0.039
Race 0.99 0.86–1.13 0.911
Gender 0.98 0.86–1.12 0.850
Coronary artery disease 1.15 0.93–1.32 0.130
Hypertension* 1.50 1.29–1.75 0.009
Congestive heart failure 1.02 0.89–1.17 0.867
Diabetes 1.09 0.31–3.99 0.988
Pulmonary disease 0.79 0.52–1.22 0.346
Perioperative CCB 0.76 0.37–1.59 0.547
Perioperative beta-blocker 0.46 0.17–1.39 0.102
Perioperative antiarrhythmics 0.39 0.23–2.88 0.178
Perioperative digoxin 0.82 0.66–1.03 0.103
Electrocardiographic parameters
PR interval 0.78 0.16–6.82 0.544
QRS duration 1.80 0.18–6.02 0.968
Right BBB 0.88 0.15–4.10 0.400
Left BBB 1.20 0.37–3.68 0.921
Hemiblocks 1.38 0.29–4.98 0.532
Echocardiographic parameters
Left ventricular ejection fraction* 2.67 1.08–7.25 0.045
Left ventricle size 0.81 0.27–2.61 0.799
Right ventricle dysfunction* 2.96 1.19–7.06 0.029
Right atrium size* 5.41 1.09–22.36 0.032
Left atrium size* 1.20 1.06–1.43 0.042
Operative variables
CPB time 0.96 0.93–1.01 0.090
Mitral ring size 0.81 0.33–3.01 0.741
MAZE 1.63 0.44–9.22 0.486
Tricuspid valve repair 0.49 0.14–1.65 0.245
Tricuspid ring size 1.86 0.27–8.68 0.574
*Asterisks identify statistically significant predictors of atrial arrhythmias. Perioperative antiarrhythmics include sotalol and amiodarone;  
BBB — bundle branch block; CCB — calcium channel blocker; CI — confidence interval; CPB — cardiopulmonary bypass time; RR — relative risk
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patients in their series recovered AV conduction 
(44% vs. 55% in our cohort). Another significant 
difference was higher mortality on their series: 
it was 1.7% as compared to zero in our patient 
population. The need for PPI was similar to our 
study; 3 (2.6%) patients had PPI an average of 
18 days after surgery. In all patients, it was due 
to persistent complete AV block, which occurred 
immediately after surgery. This is in contrast to our 
study that had 2% need for PPI, 4 due to AV block 
and 2 due to sinus bradycardia. Since the incidence 
of PPI was low, we could not extract any meaningful 
conclusion regarding potential risk factors for PPI.
Based on previously published data, there are 
no strong predictors for postoperative AV block in 
patients undergoing MVR. Nonetheless, we found 
that age, preexisting RBBB, mitral valve ring size, 
and bypass time to be associated with the deve-
lopment of CD. Only bypass time and preexisting 
RBBB were independent predictors of postopera-
tive CD. This remains in contrast to another study 
that found a modest interaction between risk of po-
stoperative AV block and body temperature during 
cardiopulmonary bypass time. Our study was not 
designed to understand the mechanisms leading to 
postoperative CD but it could be speculated that 
variables related to intraoperative “ischemic time” 
like body temperature or duration of cardiopulmo-
nary bypass time, and degree of mechanical disrup-
tion by a larger ring size, could cause reversible 
injury to the AV conduction system followed by 
spontaneous recovery in most patients. Preexisting 
abnormalities in the right bundle probably increase 
the propensity of the patient to develop CD after 
they sustain mechanical trauma to the left bundle 
system during MVR. Moreover, the characteristics 
of the conduction system, which differ from those 
of cardiomyocytes, make it more susceptible to 
ischemia during cardioplegia, which may account 
for this clinical observation.
Atrial fibrillation, the most common arrhyth-
mia after cardiac surgery, occurs with an incidence 
after valvular surgery that exceeds that after 
coronary artery bypass surgery. In comparison 
to the 17% to 33% incidence of postoperative AF 
following coronary bypass surgery, AF develops 
after cardiac valvular surgery in 38% to 64% of 
patients [14]. The frequency of AA in our study was 
significantly lower than in prior reports. Similar 
studies found that as many as 36% of the patients 
undergoing MVR would develop AF [9] compared 
to only 13.1% in our analysis. In this study, the 
investigators found that advanced age, mitral steno-
sis, LA enlargement, use of systemic hypothermia, 
and a history of cardiac surgery were independent 
predictors of postoperative AF included. How-
ever, only advanced age, mitral stenosis, and LA 
enlargement were confirmed as independent risk 
factors in a validation cohort. Our analysis in pa-
tients who underwent exclusively MVR revealed 
that atrial enlargement, hypertension, and LV or 
RV dysfunction were predictors of all AA; but like 
in the former study only age and LA enlargement 
remained statistically significant as independent 
predictors. It must be underscored that a funda-
mental difference between this 2 studies is the fact 
that we excluded patients with mitral stenosis and 
prior cardiac surgery.
Limitations of the study
The main limitation of this study arises from 
the retrospective nature. In addition, ours is 
a high-volume mitral valve reference center, and 
this series represents a single surgeon’s highly 
specialized team results; hence, we cannot exclude 
the possibility of confounders or selection bias as 
all the patients in our cohort. Therefore, our con-
clusions should be considered strictly hypothesis 
generating. Also, the low event rate of PPI makes 
it difficult to extract any conclusion regarding 
the impact of risk factors for CD on rates of PPI. 
The inclusion of patients undergoing concomitant 
TVR, CABG, PFO closure, and MAZE introduces 
major confounders that could have an impact on 
the results of our analysis. Finally, our study did 
not include any long-term follow-up, precluding 
any determination of whether postoperative CD 
and AA were associated with long-term morbidity 
and/or mortality. Nevertheless, the strength of the 
data comes from the fact that this is a large sample 
of patients undergoing MVR. While we identified 
risk factors for the development of CD and AA, 
validation of these findings in a prospective fashion 
is warranted.
Conclusions
In this large sample of patients undergoing 
MVR, the incidence of CD, AA and the need for 
pacemaker are lower than in prior reports of mitral 
valve surgery. We found that bypass time and pree-
xisting RBBB were independent predictors of CD; 
age and LA size were independent predictors of 
AA. The implications of our findings related to risk 
factors and natural history of CD and AA in patients 
undergoing MVR, may influence the perioperative 
management of these patients. Importantly, mea-
sures directed at preventing or promptly treating 
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both CD and AA appear to be warranted since 
both increase utilization of resources (electrical 
cardioversion and length of stay). The extent to 
which the variables reported in this study predict 
the occurrence of CD and AA should be evaluated 
prospectively.
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